Provided are methods and compositions useful for the diagnosis, prognosis
and treatment of hepatic cellular proliferative disorders. The methods
include the modulation or analysis of hypemethylated
glutathione-S-transferase nuleic acid sequence in hepatic samples and
biological fluids.
